Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Diagnostic Medical Systems's EV-to-OCF or its related term are showing as below:
XPAR:ALDMS'
s EV-to-OCF Range Over the Past 10 Years
Min: -55.32 Med: -9.17 Max: 101.82
Current: 10.68
During the past 13 years, the highest EV-to-OCF of Diagnostic Medical Systems was 101.82. The lowest was -55.32. And the median was -9.17.
XPAR:ALDMS's EV-to-OCF is ranked worse than 56.46% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 7.915
vs XPAR:ALDMS: 10.68
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Diagnostic Medical Systems (XPAR:ALDMS) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Diagnostic Medical Systems's PE Ratio (TTM) for today is calculated as:
Diagnostic Medical Systems's share price for today is €1.015.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Diagnostic Medical Systems's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.140.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Diagnostic Medical Systems EV-to-OCF Related Terms
Diagnostic Medical Systems EV-to-OCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Diagnostic Medical Systems's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Diagnostic Medical Systems EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Diagnostic Medical Systems's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Diagnostic Medical Systems's EV-to-OCF falls into.
Diagnostic Medical Systems's current Enterprise Value is €38.45 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Diagnostic Medical Systems's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was €3.60 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Diagnostic Medical Systems (XPAR:ALDMS) has a EV-to-OCF of 10.68 as of Aug. 27, 2026. According to the industry distribution chart, Diagnostic Medical Systems ranks #481 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 56.5%.
Is Diagnostic Medical Systems' EV-to-OCF too high?
Diagnostic Medical Systems' current EV-to-OCF is 10.68. The Medical Devices & Instruments industry median EV-to-OCF is 7.92. Diagnostic Medical Systems' value of 10.68 is 34.9% above this industry median. Based on the distribution chart, Diagnostic Medical Systems ranks #481 out of 852 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Diagnostic Medical Systems has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Diagnostic Medical Systems' EV-to-OCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Diagnostic Medical Systems ranks #481 out of 852 companies for EV-to-OCF. This places Diagnostic Medical Systems in the lower half of its industry. The industry median EV-to-OCF is 7.92. Diagnostic Medical Systems' value of 10.68 is 34.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.92, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Diagnostic Medical Systems's current EV-to-OCF of 10.68 is 34.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Diagnostic Medical Systems's current EV-to-OCF is 10.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnostic Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Diagnostic Medical Systems (XPAR:ALDMS) is currently considered Modestly Undervalued. The stock's GF Value™ is €1.13, compared to a current price of €1.02 — trading 10.2% below its estimated fair value. The current EV-to-OCF is 10.68 and 34.9% above the Medical Devices & Instruments industry median of 7.92. Diagnostic Medical Systems' overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Diagnostic Medical Systems (XPAR:ALDMS), the current EV-to-OCF is 10.68 as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Diagnostic Medical Systems (XPAR:ALDMS) Overvalued in 2026?
Based on GuruFocus' analysis, Diagnostic Medical Systems stock appears to be undervalued.
The current stock price of €1.02 is trading 10.2% below its estimated GF Value™ of €1.13.
GuruFocus considers Diagnostic Medical Systems to be Modestly Undervalued.
Key valuation signals for XPAR:ALDMS:
EV-to-OCF: 10.68
GF Value™: €1.13 vs. price of €1.02 (10.2% below fair value)
Industry Position: 34.9% above the Medical Devices & Instruments median (#481 of 852)
No single metric tells the full story. See the XPAR:ALDMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Diagnostic Medical Systems is France's company engaged in the development, design, and production of imaging systems for digital and conventional radiology and osteodensitometry. The group's activity is organized around two sectors: Radiology equipment and osteodensitometers sales: mobile radiology units, floating table tops, operating room mobile amplifiers, ultrasound osteodensitometers (designed to chart the bone micro-architecture) and X ray osteodensitometers (designed to measure bone density), etc. The group also proposes devices distribution and maintenance activities; and the Development of biotechnology solutions: in the fields of arthrosis treatment and regenerative medicine.
66GF Score
Get the complete analysis for XPAR:ALDMS
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:ALDMS has been successfully added to your 
